Search results
Order by most recent / most popular / relevance
Results: 1-4 of 4
Full Federal Court upholds Merck’s appeal in the VIOXX Representative Proceeding
- Piper Alderman
- -
- Australia
- -
- November 30 2011
The Full Court recently upheld the appeal in the VIOXX Representative Proceeding, which will have impact on the proof required by applicants in similar actions
The patentability of biological material summary of public submissions to senate inquiry
- Piper Alderman
- -
- Australia
- -
- June 7 2011
The patentability of biological material is a highly contentious issue within the scientific community and a Bill currently before a Senate committee has generated further debate
Operation of the data exclusivity regime in Australia
- Piper Alderman
- -
- Australia
- -
- June 7 2011
The data exclusivity regime was introduced in 1998 to protect data which innovator companies submit in support of registration of products in the Australian Register of Therapeutic Goods (ARTG) which contain new “active components”
The public debate about the patentability of biological material: is it much ado about nothing?
- Piper Alderman
- -
- Australia
- -
- February 11 2011
For more than 20 years, the patentability of genes and genetic material has been controversial
Current Search
- Firm Name - Piper Alderman
- Author - Dr Teresa Nicoletti
- Workarea - Litigation